Targeting chemotactic signaling has been a trend in stroke intervention [40, 41], as we observed in our experiments that upregulated OPN/SPP1 signaling, while inhibition of OPN reduces neuroinflammation and improves neurological function. This evidence concerns the gene SPP1 and stroke disorder.